Integrated Medical Professionals, a Multi-Specialty Physician Group and Solaris Health Affiliate, Adopts Single-Use Cystoscopy from Ambu | Business

COLUMBIA, Maryland–(BUSINESS WIRE)–May 4, 2022–

Ambu Inc., the global leader in single-use endoscopy, today announced that Integrated Medical Professionals PLLC, a group of multi-specialty physicians operating in the New York metropolitan area, is adopting aScope™ 4 Cysto monitors. and aView™2 Advance HD from Ambu.

This press release is multimedia. View the full press release here:

Ambu is seeing rapid adoption of its sterile, single-use aScope™ 4 Cysto in healthcare facilities across the United States (Photo: Business Wire)

IMP was formed in 2006 by 31 physicians from 13 different practices and has grown to 100 physicians treating patients at nearly 50 sites in the New York metro area. Dr. Kathleen L. Latino, IMP medical director and urologist, sees the adoption of single-use as a step forward for physicians and patients, citing the potential of single-use cystoscopy to improve efficiency and workflow in their clinics while providing a better patient experience.

“We are thrilled to partner with Ambu, the most innovative single-use endoscopy company,” said Dr. Latino. “IMP is constantly on the lookout for new innovations and technologies that allow us to become more efficient and provide better patient care. We have been very impressed with the performance of Ambu’s disruptive, high-quality single-use cystoscope platform. This allows us to eliminate costly repairs, tedious and tedious rework, and helps improve workflow efficiency.

Flexible cystoscopes were recently classified as high-risk flexible endoscopes by the Association for the Advancement of Medical Instrumentation® (AAMI), with the recommendation to sterilize reusable devices between patient uses, when possible.

The U.S. Food and Drug Administration announced in April 2021 that it was investigating “numerous” medical device reports (MDRs) describing patient infections and other contamination issues possibly associated with reprocessed urological endoscopes, including cystoscopes.

As reprocessing guidelines become increasingly comprehensive and stringent, single-use cystoscopy is an attractive and cost-effective alternative for office and hospital clinics.

“We are delighted that IMP has adopted Ambu’s sterile, single-use aScope 4 Cysto and has already used it successfully on many patients,” said Ambu President Steven Block. “We continue to see rapid adoption of the aScope 4 Cysto in healthcare facilities across the United States and are excited to see the positive impact for hospitals, clinics, physicians and staff.”

The aScope™ 4 Cysto and aView 2 Advance are under contract with all major US Purchasing Groups (GPOs).

About Ambu

Ambu has been bringing the solutions of the future to life since 1937. Today, millions of patients and healthcare professionals around the world depend on the efficiency, safety and performance of our solutions for endoscopy, anesthesia and disposable patient monitoring device. We are constantly looking to the future with a commitment to providing quality, innovative products that have a positive impact on patient care and the work of healthcare professionals. Based near Copenhagen in Denmark, Ambu employs around 4,500 people in Europe, North America and Asia-Pacific. For more information, please visit or

See the source version on


Klaas-Pieter Jimmink, Director of Marketing Communications, tel. 443-766-1363, email:

Ambu Inc., 6230 Old Dobbin Lane, Suite 250, Columbia, Maryland, 21045, USA, www.ambuusa.comEuropean Media and APAC

Mikkel Trier Wagner, Director Corporate Communications, tel. +45 4191 0830, email:

Ambu A/S, Baltorpbakken 13, 2750 Ballerup, Denmark, Tel. +45 7225 2000, CVR no.: 63 64 49 19,



SOURCE: Ambu Inc.

Copyright BusinessWire 2022.

PUB: 04/05/2022 08:30 / DISC: 04/05/2022 08:32

Copyright BusinessWire 2022.


Leave a Comment